MHRA to consult on Cyclo-f

The Medicines and Healthcare products Regulatory Agency is to carry out a consultation on whether Cyclo-f, a medicine for the treatment of heavy periods, should be available over the counter.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here